483
BTI FiltrationBTI Filtration – FDA 483, Dec 3, 2025
Record Details
An FDA inspection of BTI Filtration in Oklahoma City, OK, revealed one significant observation regarding the firm's quality system. The inspection found that a risk analysis had not been performed for their Class II BTI Filtration Deionization and Carbon Exchange System, which is used in hemodialysis water treatment systems. This indicates a lapse in a critical quality control process for a medical device.
- Office
- Dallas District Office
- Person
View Company Profile
ID · 01d83666-f255-4b9f-ba12-ed122fa5b9b2
Other documents for BTI Filtration
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.